Cinemark Holdings, Inc. Stock 12‑Month Price Target Raised to $42.62, Implies 10% Upside

Analysts raised Cinemark Holdings' 12-month price target from $42.23 to $42.62, with a range of $34 to $48. The new target suggests 10% upside from the Nov. 2 closing price. All 13 analysts maintain a 'Buy' consensus rating, with 8 Buys and 5 Holds.

Original reporting
Published Nov 3, 2026, 10:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 10:32 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cinemark Holdings, Inc. Stock 12‑Month Price Target Raised to $42.62, Implies 10% Upside — source image
Decision brief

The 30-second read

$CNKBullishLow
01

Why it matters

The upward revision signals confidence in near‑term performance, but the modest magnitude suggests limited trading urgency.

02

Market read

Analyst target lift provides a small bullish cue for CNK, but overall market impact is modest.

03

What to watch

Potential impact of streaming competition and macro‑economic pressures.

Relevance 4/10Novelty 4/10Timing: today

Background

Cinemark Holdings operates movie theaters; analyst price‑target updates reflect expectations for earnings and cash flow.

Company-level read

Ticker impact

$CNKBullishHigh confidence
Context

Analysts raised Cinemark's average 12‑month price target to $42.62, implying ~10% upside.

Expected impact

potential modest upside as market prices in the higher target

Evidence & confidence

New price‑target data from 13 analysts indicates a fresh bullish view.

Market effects

May slightly lift the entertainment/film exhibition sector.

U.S. equity market could see minor positive bias for cinema stocks.

Limited to investors tracking analyst target revisions.

Counterpoint

Target raise may be premature if foot traffic remains weak.

Key entities

  • Cinemark Holdings, Inc.

    U.S. cinema operator (ticker CNK).

Related articles

$CNKHigh

Morgan Stanley upgrades Cinemark stock rating on box office outlook

Morgan Stanley upgraded Cinemark (CNK) to Overweight with a $50 price target, citing optimism about 2027 box office growth and the company's strong market position. Cinemark's stock has risen 75.3% year-to-date, trading near its 52-week high. The company reported record Q3 earnings of $1.04 per share on $1.06 billion revenue, exceeding expectations. Other analysts have also raised their price targets following the strong performance.

$CNKHighAI 8/10

StoneX raises Cinemark stock price target on strong quarter

StoneX raised its price target on Cinemark (NYSE:CNK) to $45 from $40, citing strong Q3 results with revenue and adjusted EBITDA exceeding estimates. The firm expects continued growth in 2027, supported by a strong film slate and premium expansion. Cinemark's stock has surged 42% in six months. The company reported record Q3 earnings of $1.04 per share, beating estimates, with revenue reaching $1.06 billion.

$CNKMedAI 8/10

Cinemark stock holds at Neutral as B.Riley keeps $42 target

B.Riley maintained a Neutral rating and $42 price target for Cinemark (CNK) after its Q3 earnings beat estimates. Revenue was $1.059B, EBITDA $268M, driven by Latin America sales. Management is optimistic about future box office growth. Shares are up 65% YTD, trading near a 52-week high. Wells Fargo raised its target to $42, citing international success.

$CNKMed

Cinemark Holdings Inc (CNK) (Q3 2026) Earnings Call Highlights: Record Q3 Revenue

Cinemark Holdings (CNK) reported record Q3 2026 revenue, but faced market share compression due to film mix and capacity constraints. The company expects similar challenges in Q4. Cinemark declined to book Netflix's 'Cliff Booth' on IMAX, citing concerns about the release model. Inflationary pressures and capacity constraints are impacting operations. The company has excess cash and may increase buybacks or dividends. CapEx could rise to invest in new builds and theater enhancements.